Loading…
Loading…
CNTA (Centessa Pharmaceuticals plc) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| APGE | Apogee Therapeutics, Inc. | $134.20 | $8.3B |
| CGON | CG Oncology Inc. | $71.72 | $6.3B |
| XENE | Xenon Pharmaceuticals Inc. | $66.74 | $5.3B |
| CELC | Celcuity Inc. | $91.69 | $4.5B |
| LEGN | Legend Biotech Corporation | $23.54 | $4.4B |
| DYN | Dyne Therapeutics, Inc. | $23.83 | $3.9B |
| RARE | Ultragenyx Pharmaceutical Inc. | $28.62 | $2.8B |
| SLNO | Soleno Therapeutics, Inc. | $53.01 | $2.8B |
| ZLAB | Zai Lab Limited | $20.48 | $2.3B |
| AAPG | Ascentage Pharma Group International | $19.10 | $1.8B |